文献速递泌尿生殖与妇科肿瘤放疗放疗物理与技术

多中心评估前列腺癌Pareto导航引导的自动放疗计划方案

Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer.
PubMed 文献 · Radiat Oncol · 2024-04-08

研究在两个外部机构随机选取各30例既往前列腺癌患者,其中10例用于校准、20例用于验证,利用Pareto导航校准接口调整自动计划协议以匹配机构临床偏好。结果显示直肠平均剂量分别降低3.7 Gy和1.8 Gy(p < 0.001),盲审中31/40例自动计划优于临床计划,但适形性有所下降。

要点

  • Pareto导航校准接口可直观调整自动计划协议以匹配机构临床偏好。
  • 直肠平均剂量IA降低3.7 Gy、IB降低1.8 Gy(p < 0.001)。
  • 盲审中31/40例自动计划被认为优于临床计划。

核心结论

  • Pareto导航引导的自动计划(PGAP)使自动协议能直观适应机构计划目标,产生的计划比本地手工临床计划更符合机构临床偏好。

研究设计与样本

  • 多机构验证研究,在两个外部机构(IA和IB)各随机选取30例既往前列腺癌患者,10例用于校准、20例用于验证。
  • PGAP方法在RayStation中通过脚本开发,由基于「协议驱动自动迭代优化」计划框架的Pareto导航校准接口组成。
  • 为每例验证患者生成单一自动计划(VMATAuto),并与既往治疗临床计划(VMATClinical)进行量化和盲审定性比较。

主要发现

  • 直肠多数剂量指标明显改善,IA的Dmean降低3.7 Gy、IB降低1.8 Gy(p < 0.001)。
  • 膀胱低剂量和中剂量指标IB降低而IA升高,差异有统计学意义(p < 0.05)但较小且不被认为有临床相关性。
  • 直肠剂量降低未以PTV覆盖为代价(VMATAuto的D98%总体改善),但对PTV适形性有一定不利影响。
  • 优先考虑直肠而非适形性与校准中表达的偏好一致,是两机构明显偏好VMATAuto的关键驱动因素,盲审中31/40例被认为优于VMATClinical。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current automated planning solutions are calibrated using trial and error or machine learning on historical datasets. Neither method allows for the intuitive exploration of differing trade-off options during calibration, which may aid in ensuring automated solutions align with clinical preference. Pareto navigation provides this functionality and offers a potential calibration alternative. The purpose of this study was to validate an automated radiotherapy planning solution with a novel multi-dimensional Pareto navigation calibration interface across two external institutions for prostate cancer. METHODS: The implemented 'Pareto Guided Automated Planning' (PGAP) methodology was developed in RayStation using scripting and consisted of a Pareto navigation calibration interface built upon a 'Protocol Based Automatic Iterative Optimisation' planning framework. 30 previous patients were randomly selected by each institution (IA and IB), 10 for calibration and 20 for validation. Utilising the Pareto navigation interface automated protocols were calibrated to the institutions' clinical preferences. A single automated plan (VMATAuto) was generated for each validation patient with plan quality compared against the previously treated clinical plan (VMATClinical) both quantitatively, using a range of DVH metrics, and qualitatively through blind review at the external institution. RESULTS: PGAP led to marked improvements across the majority of rectal dose metrics, with Dmean reduced by 3.7 Gy and 1.8 Gy for IA and IB respectively (p < 0.001). For bladder, results were mixed with low and intermediate dose metrics reduced for IB but increased for IA. Differences, whilst statistically significant (p < 0.05) were small and not considered clinically relevant. The reduction in rectum dose was not at the expense of PTV coverage (D98% was generally improved with VMATAuto), but was somewhat detrimental to PTV conformality. The prioritisation of rectum over conformality was however aligned with preferences expressed during calibration and was a key driver in both institutions demonstrating a clear preference towards VMATAuto, with 31/40 considered superior to VMATClinical upon blind review. CONCLUSIONS: PGAP enabled intuitive adaptation of automated protocols to an institution's planning aims and yielded plans more congruent with the institution's clinical preference than the locally produced manual clinical plans.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Wheeler PA, West NS, Powis R, et al. Multi-institutional evaluation of a Pareto navigation guided automated radiotherapy planning solution for prostate cancer. Radiat Oncol. 2024. PMID: 38589961. doi:10.1186/s13014-024-02404-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。